Anti-Human MMP9 Therapeutic Antibody (Andecaliximab)

Recombinant monoclonal antibody to MMP9. Andecaliximab is a human monoclonal antibody that can be potentially used in the treatment of Crohn's disease (CD), Colitis, ulcerative (UC), Solid tumors.
Supplier Creative Biolabs
Product # TAB-002ML
Pricing Inquiry
Host Human
Target MMP9
Species Reactivity Human
Type IgG4, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback